(Q46833945)

25 December 2017

title

C-reactive protein and its role in metabolic syndrome: mendelian randomisation study (English)

1 reference

25 December 2017

1 reference

1 reference

25 December 2017

Deborah A. Lawlor

1 reference

25 December 2017

Tom R. Gaunt

1 reference

25 December 2017

Lyle J. Palmer

1 reference

25 December 2017

George Davey Smith

1 reference

25 December 2017

Andrew Tym Hattersley

Andrew T Hattersley

1 reference

25 December 2017

Shah Ebrahim

1 reference

25 December 2017

Gordon Matthew Lowe

Gordon D O Lowe

1 reference

25 December 2017

Ann Rumley

Ann Rumley

1 reference

25 December 2017

Roger Harbord

Roger M Harbord

1 reference

25 December 2017

author name string

Ian N M Day

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

25 December 2017

published in

The Lancet

1 reference

25 December 2017

volume

366

1 reference

25 December 2017

issue

9501

1 reference

25 December 2017

page(s)

1954-1959

1 reference

25 December 2017

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

C-reactive protein levels and outcomes after statin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Coming of age of C-reactive protein: using inflammation markers in cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Endothelial inflammation in insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

CRP or not CRP? That is the question

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Association of C-Reactive Protein With Blood Pressure and Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Associations of fibrinogen and C-reactive protein with prevalent and incident coronary heart disease are attenuated by adjustment for confounding factors. British Women’s Heart and Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Body mass index, diabetes, and C-reactive protein among U.S. adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Human CRP Gene Polymorphism Influences CRP Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

An introduction to instrumental variables for epidemiologists.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Mendelian randomization: prospects, potentials, and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Sifting the evidence-what's wrong with significance tests?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

1 reference

7 January 2021

Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

A Survey of Weak Instruments and Weak Identification in Generalized Method of Moments

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

The effects of human population structure on large genetic association studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

Genetic epidemiology and public health: hope, hype, and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967786-0

7 January 2021

10.1016/S0140-6736(05)67786-0

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017